000 | 01982 a2200577 4500 | ||
---|---|---|---|
005 | 20250516201721.0 | ||
264 | 0 | _c20140930 | |
008 | 201409s 0 0 eng d | ||
022 | _a1462-0332 | ||
024 | 7 |
_a10.1093/rheumatology/keu004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCiccia, Francesco | |
245 | 0 | 0 |
_aRituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome. _h[electronic resource] |
260 |
_bRheumatology (Oxford, England) _cJul 2014 |
||
300 |
_a1313-20 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xpharmacology |
650 | 0 | 4 |
_aAntirheumatic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aInterferons |
650 | 0 | 4 |
_aInterleukin-17 _xmetabolism |
650 | 0 | 4 |
_aInterleukin-23 _xmetabolism |
650 | 0 | 4 |
_aInterleukins _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMast Cells _xdrug effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aSTAT3 Transcription Factor |
650 | 0 | 4 |
_aSalivary Glands _xdrug effects |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aSjogren's Syndrome _xdrug therapy |
650 | 0 | 4 |
_aTh17 Cells _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aGuggino, Giuliana | |
700 | 1 | _aRizzo, Aroldo | |
700 | 1 | _aAlessandro, Riccardo | |
700 | 1 | _aCarubbi, Francesco | |
700 | 1 | _aGiardina, AnnaRita | |
700 | 1 | _aCipriani, Paola | |
700 | 1 | _aFerrante, Angelo | |
700 | 1 | _aCannizzaro, Alessandra | |
700 | 1 | _aGiacomelli, Roberto | |
700 | 1 | _aTriolo, Giovanni | |
773 | 0 |
_tRheumatology (Oxford, England) _gvol. 53 _gno. 7 _gp. 1313-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/keu004 _zAvailable from publisher's website |
999 |
_c23616577 _d23616577 |